Evidence map›Paper›PMID 36635494›Full record

ReviewNeurocritical care2023

Bayes' Theorem in Neurocritical Care: Principles and Practice.

Natasha A Jawa, David M Maslove

Abstract readReview
PubMed Publisher
In one paragraph

Review in Neurocritical care, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Natasha A JawaCenter for Neuroscience Studies, Faculty of Health Sciences, Queen's University, Kingston, ON, Canada.
David M MasloveDepartment of Critical Care Medicine, Queen's University, Kingston, ON, Canada. david.maslove@queensu.ca.ORCID 0000-0002-0765-7158

Funding

CIHR
6 · The paper itself

Abstract

Patients with critical neurological illness are diverse. As a result of the heterogeneity of this patient population, standardized approaches to patient management might not confer benefit. A precision medicine approach to neurocritical care is therefore urgently needed to improve our understanding of neurocritical illness and the care provided to this vulnerable cohort. Research designs and approaches based on Bayesian models have the potential to meet this need, as they are specifically designed to evolve with emerging evidence. This adaptability provides a benefit over the popular frequentist statistical approach, as it provides a way of adjusting hypotheses and trial procedures to maximize efficacy. This review summarizes the current state of knowledge on Bayes' theorem, and its potential applications to the field of neurocritical care. We review the basic principles underlying Bayes' theorem, compare the use of Bayesian versus frequentist statistics in medicine, and discuss the relevance of Bayesian statistics to the field of neuroscience and to clinical research. Finally, we explore the potential benefits of employing Bayesian methods within the field of neurocritical care as a steppingstone toward implementing precision medicine approaches to improve patient outcomes for complex, heterogeneous disorders.

Indexed as

Precision MedicineAdaptive Clinical Trials as TopicBayes TheoremHumansAdaptive randomizationBayes theoremCritical careNeurocritical careNeurologyPlatform trials

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.